Cargando…
Molecular modeling studies suggest that zinc ions inhibit HIV-1 protease by binding at catalytic aspartates.
Human immunodeficiency virus type 1 protease is inhibited in vitro by zinc ions at neutral pH. The binding site of these ions is not known; however, experimental data suggest that binding may occur in the active site. To examine the possibility of zinc binding in the active site, molecular dynamics...
Autores principales: | York, D M, Darden, T A, Pedersen, L G, Anderson, M W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1519788/ https://www.ncbi.nlm.nih.gov/pubmed/8404763 |
Ejemplares similares
-
Interaction of HIV-1 aspartic protease with its inhibitor, by molecular dynamics and ab initio fragment molecular orbital method
por: Koyano, Kazuo, et al.
Publicado: (2008) -
Molecular modeling and prediction of binding mode and relative binding affinity of Art-Qui-OH with P. falciparum Histo-Aspartic Protease (HAP)
por: Mahapatra, Rajani Kanta, et al.
Publicado: (2012) -
Catalytic Site pK(a) Values
of Aspartic, Cysteine, and Serine Proteases: Constant pH MD Simulations
por: Hofer, Florian, et al.
Publicado: (2020) -
Dataset of cocoa aspartic protease cleavage sites
por: Janek, Katharina, et al.
Publicado: (2016) -
Structure-Based Optimization of Inhibitors of the Aspartic Protease Endothiapepsin
por: Hartman, Alwin M., et al.
Publicado: (2015)